COMMUNIQUÉS West-GlobeNewswire

Chi-Med Initiates a Phase Ib/II Proof-of-Concept Trial of Sulfatinib in Pancreatic Neuroendocrine Tumors and Biliary Tract Cancer in the United States
23/07/2018
LONDON, July 23, 2018 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“ Chi-Med ”) (AIM:HCM) (Nasdaq:HCM) has initiated a Phase Ib/II proof-of-concept study of sulfatinib in pancreatic neuroendocrine tumors (“NET [...]
Novartis renews drug donation of Egaten® (triclabendazole) until 2022, reaffirming its commitment to the fight against liver fluke
23/07/2018
Novartis extends agreement with the WHO for the donation of Egaten ® for the treatment of liver fluke, a neglected tropical disease, also known as fascioliasis, that infects more than 2.4 million people globally[1] [...]
MDxHealth (R): Medicare Establishes Final Positive Local Coverage Determination for Use of ConfirmMDx for Prostate Cancer
23/07/2018
NEWS RELEASE Providing Nationwide Coverage for Medicare Patients IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, July 23, 2018 - MDxHealth SA (Euronext: MDXH.BR), today announced that Palmetto GBA, a Medicare [...]
MDxHealth (R) :
23/07/2018
MDxHealth (R): Medicare Establishes Final Positive Local Coverage Determination for Use of ConfirmMDx for Prostate Cancer
23/07/2018
NEWS RELEASE Providing Nationwide Coverage for Medicare Patients IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, July 23, 2018 - MDxHealth SA (Euronext: MDXH.BR), today announced that Palmetto GBA, a Medicare [...]
MDxHealth (R) :
23/07/2018
MDxHealth (R): Medicare Establishes Final Positive Local Coverage Determination for Use of ConfirmMDx for Prostate Cancer
23/07/2018
NEWS RELEASE Providing Nationwide Coverage for Medicare Patients IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, July 23, 2018 - MDxHealth SA (Euronext: MDXH.BR), today announced that Palmetto GBA, a Medicare [...]
MDxHealth (R) :
23/07/2018
MDxHealth (R) : MDxHealth reçoit une détermination de couverture locale finale positive de la part de Medicare pour l'utilisation de ConfirmMDx for Prostate Cancer
23/07/2018
Assurer une couverture à l'échelle nationale pour les patients Medicare IRVINE, CA, et HERSTAL, BELGIQUE - 07h00 CEST, 23 juillet 2018 - MDxHealth SA (Euronext : MDXH.BR), a annoncé aujourd'hui que Palmetto GBA, un sous [...]
BeiGene Announces Preliminary Topline Results of Pivotal Trial in China for Anti-PD-1 Antibody Tislelizumab in Hodgkin’s Lymphoma
22/07/2018
BEIJING, China and CAMBRIDGE, Mass., July 22, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted [...]
BeiGene Announces Plan to Pursue Accelerated Approval in the U.S. of BTK Inhibitor Zanubrutinib in Waldenström Macroglobulinemia (WM)
22/07/2018
Fast Track Designation Granted by U.S. FDA Enrollment Complete in Global Phase 3 Clinical Trial in WM CAMBRIDGE, Mass. and BEIJING, China, July 22, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a commercial- [...]
PotNetwork Holdings, Inc. Withdraws Form 10 due to Unrelated PCAOB Action Against Its Auditor – Refiling Planned
22/07/2018
FT LAUDERDALE, Fla., July 22, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holdings, Inc. (OTC Pink:POTN) announced today that the Company on July 20 th filed a request with the Securities and Exchange [...]
Arcturus Therapeutics Announces Annual and Extraordinary General Meeting of Shareholders to Be Held on August 24, 2018
20/07/2018
SAN DIEGO, July 20, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (“ Arcturus ” or the “ Company ”) (NASDAQ:ARCT), an RNA medicines company, today announced that it will hold an Annual and Extraordinary General [...]
Digirad Corporation to Release 2018 Second Quarter Financial Results on August 2, 2018
20/07/2018
Conference Call and Webcast Set for 11:00 a.m. EDT SUWANEE, Ga., July 20, 2018 (GLOBE NEWSWIRE) -- Digirad Corporation (NASDAQ:DRAD) will release financial results for its second quarter ended June 30, 2018, before the [...]
TESARO to Announce Second-Quarter 2018 Financial Results on August 2, 2018
20/07/2018
WALTHAM, Mass., July 20, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO) will announce second-quarter 2018 financial results on Thursday, August 2, 2018, after the close of the U.S. financial markets. TESARO’s [...]
Crinetics Pharmaceuticals Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
20/07/2018
SAN DIEGO, July 20, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq:CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]
Invuity Announces 2018 Second Quarter Financial Results and Conference Call Date
20/07/2018
SAN FRANCISCO, July 20, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that it will release its 2018 second quarter [...]
Dentsply Sirona to Host Second Quarter 2018 Conference Call on August 7th
20/07/2018
YORK, Pa., July 20, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (NASDAQ:XRAY), The Dental Solutions Company™, today announced that the Company will host an investor conference call and live webcast on Tuesday, August [...]
Collegium to Host Conference Call to Discuss Second Quarter 2018 Financial Results and Provide Corporate Update
20/07/2018
CANTON, Mass., July 20, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced today that the Company will host a conference call and live audio webcast on Wednesday, August 8, 2018 at 4:30 p.m [...]

Pages